Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Natera’s EDEN study on board
11 February 2026

Natera’s EDEN study on board

Introduction Natera, Inc., a leading clinical genetic testing company aiming on technologies for better health and organs of women. Since 2003, the company has dedicated its operations to an intensified molecular diagnostics like Panorama, Prospera and Signatera. The company’s precision in th...

CaseBioscience®’s two solutions are ready to contribute to Cell Therapy in the future
11 February 2026

CaseBioscience®’s two solutions are ready to contribute to Cell Therapy in the future

Introduction CaseBioscience®, a registered biotechnology company, is a scholar in advanced media, biopreservation solutions and cGMP-compliant mainly for cell therapy, IVF/ART, regenerative medicine and cell therapy. The company continues its business through its Stem cell Research and Assisted...

The FDA considered Pfizer’s review of sBLA in the first place
11 February 2026

The FDA considered Pfizer’s review of sBLA in the first place

Introduction Pfizer Inc., a popular multinational biopharmaceutical company with its origins in New York City, aims to discover appropriate vaccines and innovative drugs for immunology, inflammation, and oncology. Pfizer’s significant and most commercialised products include Advil, COVID-19 a...

Akeso’s one more Breakthrough Therapy Designation win
10 February 2026

Akeso’s one more Breakthrough Therapy Designation win

Introduction Akeso, Inc. is a leading biopharmaceutical company, popular for its full-fledged operation of establishing, manufacturing and marketing effective and creative antibody drugs for conditions like metabolic, immunology and oncology. Along with its exclusive Tetrabody bispecific antibody p...

What is Pfizer’s Cost Savings Program?
10 February 2026

What is Pfizer’s Cost Savings Program?

Flashback Pfizer Inc. recently raised a toast at its 175th anniversary in 2024, commemorating its immense contribution to the healthcare sector and its winning performances in the vaccine and oncology treatment areas. In 1950, the company discovered oxytetracycline, and in the 2020s onwards, the de...

Medichem to enter and explore the injectable business
10 February 2026

Medichem to enter and explore the injectable business

Introduction Medichem Solutions S.L. is the division of Medichem, a family-owned, popular international pharmaceutical company. The company is an expert in manufacturing and establishing Finished Dosage Forms and Active Pharmaceutical Ingredients. Medichem concentrates on generics and is crowned fo...

Denali’s progress reports to heal Lysosomal Storage Disorders
10 February 2026

Denali’s progress reports to heal Lysosomal Storage Disorders

Introduction Denali Therapeutics is a biotechnology company built on the promise to establish core treatments for lysosomal storage disorders and neurodegenerative diseases. To present thorough and most worthy results, the company use exclusive TransportVehicle™ platform to ease therapeutic m...

Entera and OPKO, to upgrade the PTH tablet
09 February 2026

Entera and OPKO, to upgrade the PTH tablet

Introduction One of Miami’s diamonds, OPKO Healthcare Company, is working to establish robust pharmaceutical products for extreme conditions and continues to operate under BioReference Laboratories' supervision. The company is engaged in the development of treatments such as NGENLA and Rayald...

Cheers to Balt for its PMA of the Squid™ liquid embolic agent
09 February 2026

Cheers to Balt for its PMA of the Squid™ liquid embolic agent

Introduction Balt Inc. is a medical device manufacturer that has given robust coils, catheters and stents products to the healthcare sector. With a total 950 workforce the company aims for interventional neurovascular and neuroradiology solutions. Balt met expansion for the first time after Bridgep...

Biodexa finalized deal with Otsuka, and the new license of OPB-171775 arrives
09 February 2026

Biodexa finalized deal with Otsuka, and the new license of OPB-171775 arrives

Introduction Biodexa Pharmaceuticals PLC is a known clinical-level performer, a biopharmaceutical company concentrating on rare disease and oncology treatments. The gold of the company, MTX110, implements a sharp and effective solution to brain cancers. Its comprehensive, limited yet promising pipe...

WhatsApp